Assessing the Effect of the Silver Dressing on Surgical Site Infections in Adult Patients Post Cardiac Surgery: a Single Center Randomized Control Trial
3 other identifiers
interventional
145
1 country
1
Brief Summary
RCT on post-cardiac surgery patients using silver dressings vs. standard care. Conducted in ICU, CCU, telemetry units. Outcomes assessed via checklist \& modified Parsonnet Score. Descriptive \& inferential statistics for analysis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 29, 2025
CompletedFirst Posted
Study publicly available on registry
June 6, 2025
CompletedStudy Start
First participant enrolled
June 30, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
June 6, 2025
May 1, 2025
1 year
May 29, 2025
May 29, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
silver dressing on SSI rates as compared to the standard dressing- Mepilex foam dressing in reducing SSIs.
30 days post op
Study Arms (1)
Mepilex Border Opsite dressing
OTHEROnly foam dressing used in this arm
Interventions
Silver dressing will be applied to the sternotomy and donor site wounds for the CABG patients
Eligibility Criteria
You may qualify if:
- Patients 18 years of age and older are scheduled for cardiac surgery requiring a sternotomy incision.
You may not qualify if:
- Patients who died without an infection within thirty days following surgery. Patients who had undergone another procedure through the same incision(s) within a year after enrollment in this study.
- Patients who are a redo- such as needing debridement or an infection. Patients who have an open chest Patients on ECHMO Patients excessively bleeding Patients who require the surgery as an emergency Patients with a known allergy to silver dressings
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
King Faisal Specialist Hospital and Research Center - Jeddah
Jeddah, Saudi Arabia
Related Publications (1)
Dissemond J, Bottrich JG, Braunwarth H, Hilt J, Wilken P, Munter KC. Evidence for silver in wound care - meta-analysis of clinical studies from 2000-2015. J Dtsch Dermatol Ges. 2017 May;15(5):524-535. doi: 10.1111/ddg.13233.
PMID: 28485879BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr
Study Record Dates
First Submitted
May 29, 2025
First Posted
June 6, 2025
Study Start
June 30, 2025
Primary Completion (Estimated)
June 30, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
June 6, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share
The data will not be shared due to privacy concerns and institutional policies.